PROSTia™ is a personalized in silico screening test that targets the early detection of prostate cancer.
It incorporates a standard PSA test result
and over 60 patient features.
It only requires 4 or 5 steps.

PSA Test

PROSTia relies on a standard PSA test.

PROSTia can integrate a Digital Rectal Examination result, if available.

A 5-minute short questionnaire is filled out by the patient for both PROSTia and PROSTia+.

A complex technology network powers up PROSTia.

The result sheet of PROSTia displays the likelihood of prostate cancer in the next 12 years.